拜登擬加稅 觸動炒家神經 Bitcoin跌穿5萬美元 幣市24小時蒸發2萬億 | 蘋果日報
【本報訊】比特幣(Bitcoin)等加密貨幣近期集體暴升暴跌,美國監管機構早已揚言要加強監管,加上傳出拜登政府大幅上調資本增值稅(CGT)稅率至39.6%,交易加密貨幣獲利的投資者亦受影響。消息震散加密貨幣市場,過去24小時蒸發近2,600億美元(約20,179億港元),龍頭Bitcoin一度跌穿5萬美元關,低見47,467美元。
據外電報道,投資者擔心CGT新稅率適用於加密貨幣資產,即其若持有加密貨幣超過一年,於賣出時須按增值部分繳付CGT。Miller Tabak + Co首席市場策略師馬利接受彭博訪問時表示,投資者最需要擔心的事,就是漲最多的標指最容易遭到市場賣出,因有些投資者持有龐大倉位,當政府大幅調高資本利得稅,他們可能損失慘重。
黃國英無懼加注以太幣
比特幣價格過去一周跌幅逾兩成,技術上見「熊」,但一年間比特幣升幅達5.75倍;若於2019年4月購入,這項收益更高達八倍,一旦落實拜登政府提出的加稅建議,投資人須繳交巨額稅款,讓近日處於弱勢的加密貨幣出現集體暴瀉情況。
截至昨晚9時半,Bitcoin報48,841.41美元,過去24小時跌11.4%;第二大加密貨幣以太幣(Ethereum)報2,214.8美元,跌13.88%,近日熱炒的狗狗幣報0.2199美元,更大跌22.82%。
好友古根海姆全球首席投資官Scott Minerd擔心Bitcoin短期或現泡沫,幣價可能腰斬一半至2萬美元,但他仍深信其最終見40萬至60萬美元。企業方面,電動車龍頭Tesla和支付平台Square等都配置部份資產到Bitcoin上,Tesla昨日開市升0.02%至719.8美元,Square則跌0.7%至243.39美元。
豐盛融資資產管理董事黃國英分析指,按目前消息,加稅計劃主要針對美國富人,而非全球投資者,而美國投資者可進行操作避免遭大幅徵稅,例如趁這幾天賣出加密貨幣的持倉,隔一兩天後再買入,當新稅率實施後,有望以較新且高的成本價計稅項,故此料對加密貨幣市場及美股的影響短暫。他的基金看好NFT(不可代替代幣)的應用,以太幣可受惠,故此加注相關基金COINETH。
美股昨晚早段三大指數個別發展,道指報33725點,跌90點;標普500指數報4142點,升7點,納指報13891點,73點。道指成份股美國運通公佈首季業績,期內多賺逾五倍至22.35億美元,美國運通會員撇除旅遊與娛樂後項目的消費開支按年升11%,惟期內信貸損失撥備縮減至6.75億美元,少過去年同期的2.6億美元,美國運通曾跌3.7%至141.65美元。社交通訊應用程式Snapchat母企Snap,昨日公佈業績勝預期,今年首季收入按年升66.6%至7.44億美元,每日活躍用戶按年升22%至2.8億美元。Snap曾升7.25%報61.18美元。
傳拜登政府加稅建議
•將年收入逾100萬美元人的資本增值稅(CGT)率提高近一倍至39.6%,加上現有投資收入附加稅3.8%,有關人士的聯邦稅率或達43.4%
•若按更廣泛的加稅建議,家庭收入逾40萬美元的稅率由37%提高至39.6%
•現時美國最富有的人按最高稅階37%繳付所得稅,該稅率將上調至39.6%
Why bitcoin’s pullback could be ‘healthy’ for a run to $100,000
TipRanks
Stock traders are known for their occasional love of aphorisms, and several come readily to mind. ‘Buy low, sell high’ and ‘don’t try to time the market’ are two that have stood the test of time, and while they may sound contradictory, that’s not necessarily the case. It’s possible to buy low even in an upward trend. Checking in with Wall Street’s analysts, to find out if the fundamentals are sound, can give some indications if a stock’s pullback is just a temporary event. The analysts make their reputations by finding these opportunities, and bringing them to our attention. With this mind, we’ve used the TipRanks database to search for three stocks that have seen such recent pullbacks – and that show plenty of upside potential ahead, according to the analysts. Let’s take a look at the details. Cardiff Oncology (CRDF) The first stock we’re looking at, Cardiff Oncology, is a clinical stage biopharma company with a laser-focus on cancer treatment. Specifically, the company focuses on the development of medication options for cancer patients whose current treatment has lost efficacy. Cardiff is developing onvansertib, a first-in-class, third generation Polo-like Kinase 1 (PLK1) inhibitor, designed to work in combination with existing medications to overcome treatment resistance, improve patient response, and increase survival rates. Cardiff’s current research pipeline features onvansertib in three separate clinical programs, in combination with different existing drugs to combat three different cancers. The programs are a Phase 1b clinical trial of onvansertib plus Folfiri/Avastin for the treatment of KRAS-Mutated Metastatic Colorectal Cancer (mCRC), and two Phase 2 trials, one in combination with Zytiga to treat Metastatic Castration-Resistant Prostate Cancer (mCRPC) and one to treat Relapsed/Refractory Acute Myeloid Leukemia (AML) in combination with Decitabine. Preliminary data on these studies shows positive responses to onvansertib in combination with existing therapies. In the mCRC program, 86% of evaluable patients have shown a clinical benefit, while in the mCRPC program 54% of patients across three cohorts showed a radiographic stable disease. In the AML program, 20% of patients achieved a complete remission. These early data are considered significant, and the company has plans to initiate further trials later this year. This background, along with the stock’s 50% fall year-to-date, have combined to catch the attention of 5-star analyst Jason McCarthy of Maxim Group. McCarthy points out that the shares have retreated recently due to profit-taking and broader market changes. “While valuation has pulled back since reaching a 52-week high in late 4Q, from a KRAS perspective, CRDF is not alone… and we view Cardiff as potentially having the more attractive asset in mCRC which continues to be supported with emerging data… we still see a KRAS space that will continue to be active and is of potential high value given the unmet need, a company in Cardiff that is well-financed ($130M in cash as of YE20), and a drug in onvansertib that has multiple opportunities. Combined, we see this as an opportunity to buy CRDF shares on the weakness," McCarthy opined. McCarthy puts a Buy rating on CRDF, and his $30 price target implies a robust upside of 242% from current levels. (To watch McCarthy’s track record, click here) Overall, this stock has a Strong Buy analyst consensus rating, and that verdict is unanimous, based on 3 recent positive reviews. The shares are selling for $8.76, and their $27.33 average price target suggests room for 212% appreciation this year. (See CRDF stock analysis on TipRanks) MicroStrategy (MSTR) Shifting gears, we’ll look into high-tech. Specifically, we’ll look at the world’s largest independent business intelligence company, MicroStrategy. This $6.3 billion company provides a winning combination of modern analytics, a comprehensive enterprise platform, and both cloud and on-site optimization options. MicroStrategy’s products let customers make smarter and faster decisions – a key advantage in today’s high-speed business world. MicroStrategy’s shares peaked above $1,200 early in February this year, and have since retreated some 53%. The retreat in shares comes even as the company has doubled down on its commitment to bitcoin. Management started purchasing the cryptocurrency last August, as both a store of value and an investment, and MicroStrategy now holds more than $4.4 billion in BTC. The value of the cryptocoin has more than quadrupled since MicroStrategy started the purchases. In a research report subtitled ‘Pullback Provides Attractive Entry Point,’ 5-star analyst Mark Palmer of BTIG notes two tracks for the company’s success. First, “[We] believe MSTR’s adoption of Bitcoin as its primary treasury reserve asset represents a rational action aimed at protecting the company’s inherent value in the long run. At the same time, the strategy enables MSTR to capture upside arising from the increased adoption of the cryptocurrency by institutional investors concerned about mounting inflationary pressures.” Second, Palmer goes on to add, “While most of the attention paid to MSTR has been focused on its adoption of Bitcoin as its primary treasury asset, we believe the company offers an attractive business analytics software play, especially as the company executes a shift from a product license model to a cloud-first, SaaS subscription model featuring mobile offerings.” To this end, Palmer puts an $850 one-year price target on MSTG shares, along with his Buy rating. At current levels, this price target implies an upside of 42%. (To watch Palmer’s track record, click here) MicroStrategy’s controversial bitcoin policy has generated some divisions among the Wall Street analysts, as shown by the most recent reviews – which break down to 2 to 1 to 1 in Buy/Hold/Sell. This gives the stock a Moderate Buy analyst consensus rating. The shares are selling for $601.27, and their average price target of $698.75 indicates a 16% upside for the coming year. (See MSTR stock analysis on TipRanks) Roku (ROKU) Let’s stay in the tech world, but look at online TV streaming. Roku is well known as a leader in that growing niche, where it helped to pioneer video on demand through its eponymous streaming player. The Roku player connects to the user’s TV, and the company provides connected streaming services. On Roku’s end, profits come from a combination of audience monetization and advertiser engagement. Roku shares have slipped 25% since their recent peak in February this year. But even after recent losses, the stock is still up 184% over the past 12 months. The gains reflect Roku’s 2020 successes: Revenue was up 58% yoy, to reach $1.778 billion; 14.3 million new active accounts swelled the customer rolls to 51.2 million; and 38% of all smart TVs sold in the US during 2020 were Roku models. In March of this year, Roku made two important acquisitions, adding the popular ‘This Old House’ franchise to its content line-up and partnering with Nielsen Holdings on ad and content measurement and video advertising. These moves came after Roku had, in January, acquired the rights to Quibi’s content library, now rebranded as ‘Roku Originals.’ Finally, while Roku is a content streamer – and has rightfully been focused on expanding its content offerings – it is also a tech company, with a tech company’s bent toward innovation. Earlier this month, Roku unveiled a new customer package that includes a voice activated TV remote, with a rechargeable battery, hands-free controls, and an audible remote finder. It’s a tech gadget that is sure to be appreciated on the customer end. So, Roku is making the moves expected of a tech-oriented content streaming company. However, analyst Jeffrey Rand, of Deutsche Bank, sees the company’s main path forward lying in advertising. “With ad revenue continuing to grow as a mix of revenue, we expect Roku to continue to focus its strategy on expanding its influence in the ad market. Its acquisition of Nielsen’s Advanced Video Advertising (AVA) business gives Roku an opportunity to take part in the ad market for linear TV…. We expect Roku to continue to look to invest organically and inorganically in opportunities to expand the role that it plays in the ad market, for both streaming and linear TV,” Rand noted. At the bottom line, Rand sums up Roku as a solid choice for investors seeking a relative bargain: “While many growth-oriented tech companies have faced challenges in the current environment, with the transition to streaming continuing at a rapid pace, we see the recent pullback in Roku’s stock as a good buying opportunity.” In line with this bullish outlook, Rand puts a Buy rating on ROKU shares, and his $500 price target suggests an upside of 43% over the next 12 months. (To watch Rand’s track record, click here) So, there’s Deutsche Bank’s view, but what does the rest of the analyst fraternity think? All in all, the Street maintains a positive, although slightly more reserved stance. Based on 20 analysts tracked in the past 3 months, 14 rate ROKU a Buy, while 5 say Hold, and only 1 suggests Sell. Meanwhile, the 12-month average price target stands at $476.95, marking ~36% upside from current levels. (See ROKU stock analysis on TipRanks) To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
Should you still invest in Bitcoin in 2021
People who have only recently heard about cryptocurrencies and the surge in the value of Bitcoin in particular, might think that they are irretrievably late because the value of Bitcoin has risen to such a high level. At the same time, hardcore crypto enthusiasts believe that the value of Bitcoin is going to rise and even multiply. The same dichotomy exists between the opinions of experts and investors.
Some like Elon Musk predict that Bitcoin’s value will continue to rise and encourage investing in it. Tesla even announced that it will start accepting Bitcoin payments for its cars. Others like Bill Gates are more cautious and would stay away from cryptos. So is it safe and wise to invest in Bitcoins now? The answer is the same as to any other investment, do your homework first and invest later.
Investing in Bitcoin in 2021
Investing in Bitcoin in 2021 requires several things to be considered, to be able to obtain the best possible profit for the capital invested. Firstly, it is important to know your investment target – in this case, Bitcoin. To some, this may seem like wasted time or just a plain redundant thing to do, but it is quite an important phase regardless of the form of investment. Because of that investors should focus on information about Bitcoin operations from a trustworthy site. For example, this Bitcoin site seeks to convey all the necessary information on Bitcoin in plain language, without using unnecessarily complex terminology making sure that both the beginner and the experienced person in the field of cryptocurrency, will get something out of the content.
Cyclical changes
One important part of getting to know your investment target is to understand the cyclical changes of the crypto values. Buying at the right time makes it possible to be included in the rising market. There are numerous theories and even mathematical algorithms created for predicting the ups and downs of the curve. Like any other financial asset, of course psychology of the investors and demand plays a great role, at least in short term fluctuations.
After learning enough about the topic, if the decision to invest has been made, buying Bitcoin is easy. Nowadays there are multiple trading venues accessible for every investor. There is no longer a need to operate through specialised forums or shady characters, even some trading platforms used for buying stocks or ETF have the option of investing in Bitcoin and some other cryptos.
Avoiding impulse
When investing in Bitcoin, like all other investments, one should avoid being guided by feelings, because often the worst investment decisions are made impulsively. This is true both for the decision to invest all of a sudden and fear of investing. You can usually get the best result by following the hints and analyses gathered by investment sites, and by experienced investors in cryptocurrencies. Some sites even let you see how a certain experienced investor has acted and copy that for your own investments. All in all, following fact based information, clear analyses and forecasts, you can prevent feeling based trading and won’t accidentally carry out poor investment decisions.
HT